When you have diabetes, your daily life becomes a balancing act. One minute you’re checking your blood sugar before breakfast, the next you’re wondering if that extra slice of bread will spike your numbers later. It’s not just about feeling tired or thirsty-it’s about avoiding long-term damage to your eyes, kidneys, nerves, and heart. The two most important tools for staying in control are your A1C number and your daily glucose readings. But what do those numbers really mean? And why do some doctors want you at 6.5% while others say 8% is fine?
What A1C Actually Tells You (And What It Doesn’t)
A1C is a blood test that shows your average blood sugar over the past 2 to 3 months. It’s not a snapshot like your fingerstick reading-it’s more like a video summary. When glucose floats around in your blood, it sticks to hemoglobin, the protein in red blood cells. The more glucose, the more sticking happens. That’s what A1C measures: the percentage of hemoglobin coated in sugar.
Normal is under 5.7%. Between 5.7% and 6.4% means prediabetes. 6.5% or higher? That’s diabetes. But here’s the catch: A1C doesn’t show spikes or crashes. You could have an A1C of 7% and still spend 4 hours a day above 200 mg/dL, then drop to 50 mg/dL at night. That’s called glucose variability, and it’s dangerous-even if your A1C looks good.
And A1C isn’t perfect. If you have anemia, kidney disease, or certain blood disorders, your A1C can be misleading. For example, African Americans with a common hemoglobin variant (HbS) may get falsely low readings. That’s why some doctors now pair A1C with daily monitoring instead of relying on it alone.
What Should Your A1C Target Be?
There’s no one-size-fits-all number. The American Diabetes Association says most adults should aim for under 7%. But that’s not a rule-it’s a starting point. The American College of Physicians says 7% to 8% is better for many people with type 2 diabetes, especially older adults or those with other health problems. Why? Because pushing too hard for low numbers increases the risk of dangerous low blood sugar episodes.
Think about it: if you’re 72, live alone, and take insulin, a blood sugar of 50 mg/dL while driving or cooking could be life-threatening. But if you’re 45, active, and just diagnosed with type 2, you might be able to safely aim for 6.5% and avoid complications down the road. The UKPDS study showed that for every 1% drop in A1C, microvascular complications like nerve and eye damage drop by 25%. But the ACCORD trial found that pushing A1C below 6% increased death risk by 22% in high-risk patients.
So what’s the real answer? Your target depends on:
- Your age and overall health
- How long you’ve had diabetes
- Whether you’re on insulin or pills
- Your risk of low blood sugar
- Your ability to afford supplies
There’s no shame in having a higher target. If your doctor pushes you to hit 6.5% and you end up in the ER three times last year from low blood sugar, that’s not progress-it’s harm.
Daily Glucose Monitoring: Fingersticks vs. CGMs
Before continuous glucose monitors (CGMs), people checked their blood sugar with fingersticks. You prick your finger, put a drop on a test strip, wait a few seconds, and see the number. It’s simple. But it’s also limited. You only get one point in time. You miss what happens between meals, during sleep, or after walking the dog.
CGMs like the Dexcom G7 and Abbott FreeStyle Libre 3 change everything. They’re small sensors worn on your arm or belly that measure glucose in your interstitial fluid every 5 minutes. No more 10 fingersticks a day. You get a live graph showing your trends-up, down, or steady. You see how coffee affects you. You notice your blood sugar climbs after pasta but not after rice. You catch nighttime lows before they become emergencies.
CGMs are more accurate than fingersticks too. Fingersticks can be off by ±15%, especially if your hands are cold or you didn’t wash them. CGMs are accurate within ±9 mg/dL for most values. The FDA approved both Dexcom G7 and Libre 3 in 2022. They’re also now covered by Medicare for anyone on insulin-no more rationing strips because you can’t afford them.
But here’s the problem: CGMs cost $127 a month out-of-pocket if you don’t have good insurance. And even with coverage, some patients still skip sensors because they’re expensive. A 2022 survey found 57% of users worry about cost. That’s why some people still rely on fingersticks-because they have no other choice.
Time-in-Range: The New Gold Standard
Doctors are starting to talk less about A1C and more about time-in-range. That’s the percentage of time your blood sugar stays between 70 and 180 mg/dL. The ADA now recommends aiming for at least 70% of your day in that range. That’s roughly equivalent to an A1C of 7%, but it tells you so much more.
Let’s say two people both have an A1C of 7%. Person A spends 80% of the day between 70-180 mg/dL. Person B spends 30% of the day above 200 mg/dL and 15% below 70 mg/dL. Who’s healthier? Person A. Because even though their A1C is the same, Person B is at risk for both high and low blood sugar damage.
CGMs make this easy to track. Most apps show your daily time-in-range, plus time below 70 and time above 180. You can even set alerts so your phone buzzes if your sugar drops too fast. That’s huge for people with hypoglycemia unawareness-those who don’t feel when their blood sugar crashes.
Studies show that people who focus on time-in-range have fewer complications, better sleep, and less anxiety. One 2023 NEJM Catalyst report found that combining CGM data with electronic health records improved outcomes by 18%. That’s not magic-it’s just better information.
Real People, Real Struggles
Online forums are full of stories that don’t fit the textbook. One Reddit user, ‘Type1Since98’, says their endocrinologist demands a 6.5% A1C, even though they’ve had two ER visits from low blood sugar in the past year. Another, ‘T2Mom65’, says after turning 70 and having a scary hypoglycemic episode, her doctor raised her target to 8%. She says it’s the best decision she’s ever made.
And it’s not just about numbers. A 2023 Diabetes Daily survey found 68% of users feel frustrated by rigid A1C targets. They’re tired of being judged at appointments. One person said, “I’m not lazy-I’m scared. I don’t want to be the patient who gets blamed for not hitting 7%.”
At the same time, people who just got diagnosed often say clear targets help them feel in control. A 4.7/5 rating on Healthline’s community shows that structure matters. The key is balance: goals should guide, not punish.
How to Make Monitoring Work for You
If you’re using fingersticks:
- Wash your hands with soap and water before testing-alcohol wipes aren’t enough.
- Use a fresh lancet every time. Dull needles hurt more and give bad samples.
- Store strips in a cool, dry place. Heat and humidity ruin them.
- Code your meter correctly. 12-15% of home tests are wrong because of coding errors.
If you’re using a CGM:
- Calibrate if your device asks for it (some newer ones don’t need it).
- Check your sensor site for redness or irritation-don’t ignore it.
- Sync your data daily. If you don’t look at it, you can’t learn from it.
- Use the trend arrows. Up, down, or flat-those matter more than the number.
And don’t skip education. A 2021 study found that after just three sessions with a certified diabetes educator, 78% of people could spot patterns in their glucose data. That’s the difference between guessing and knowing.
The Future Is Here-But Is It Fair?
Technology is moving fast. Hybrid closed-loop systems like Tandem Control-IQ automatically adjust insulin based on your CGM readings. Real-world data shows they increase time-in-range by 12.3% and lower A1C by half a point. Google and Dexcom are working on a contact lens that measures glucose-maybe by 2025.
But access isn’t equal. In the U.S., 74% of type 1 diabetes patients use CGMs. Only 22% of type 2 patients do. Why? Cost. Income matters. People earning over 400% of the poverty level have 89% CGM use. Those below 100%? Just 12%. A 2022 Health Affairs study found 32% of Medicaid patients ration test strips because they can’t afford more.
Diabetes care shouldn’t depend on your zip code or paycheck. The ADA’s 2024 initiative to include social determinants in target-setting is a step forward. But until insurance covers everyone equally, the gap will keep growing.
What You Can Do Today
Start with this: know your A1C number. Ask for it at every appointment. Don’t accept “it’s fine” without the number.
Ask your doctor: “What’s my time-in-range?” If they don’t know, ask for a CGM. Even if you’re on pills, not insulin, you might still benefit.
If you’re struggling with costs, talk to your pharmacist. Many manufacturers offer savings cards. Medicare now covers CGMs for insulin users. And if you’re on Medicaid, check if your state expanded coverage in 2023.
And remember: your goal isn’t perfection. It’s progress. One less low blood sugar episode. One more night sleeping through. One more week without the fear of a spike after lunch. That’s what matters.
Dan Mack
January 15, 2026 AT 19:33Amy Vickberg
January 17, 2026 AT 07:20Ayush Pareek
January 18, 2026 AT 10:16Nishant Garg
January 19, 2026 AT 17:07Nicholas Urmaza
January 20, 2026 AT 03:47Sarah Mailloux
January 20, 2026 AT 12:12Tom Doan
January 21, 2026 AT 07:00Arjun Seth
January 21, 2026 AT 22:52Mike Berrange
January 23, 2026 AT 03:47